ICBC Returns to Barcelona on 10 March 2022

The International Cannabis Business Conference (ICBC) returns to Barcelona on 10 March, a few days before and in partnership with Spannabis 2022. ICBC specializes in B2B networking in addition to offering fresh perspectives on the economic potential of the cannabis sector in Europe.

For more news like this, be sure to download our free cannabis news app.

ICBC Partners with “Spannabis”

“Spannabis is the meeting point for the entire European cannabis scene. It is primarily a consumer event, but many people who attend are also looking for a B2B element. ICBC’s partnership with Spannabis fills this gap and fills a clear need for the key players in the cannabis industry to meet, network, and advance the industry as cannabis laws are liberalized in Spain and across the continent,” said Alex Rogers, ICBC producer.

What to Expect

The ICBC day will consist of a number of conferences with various themes:

• The prospects of legalization in Spain
• Business opportunities in the different cannabis markets, with lawyer Kai-Friedrich Niermann, who has won numerous court cases in Germany
• The challenges currently faced by Cannabis Clubs in Spain

This will be followed by a networking session and an after party at the Ritz-Carlton in Barcelona.

Why go to ICBC Barcelona?

ICBC is an event that is primarily aimed at cannabis professionals in Europe. People from all walks of life will be present, including policy makers, entrepreneurs and cannabis activists. It’s the perfect place to learn about the emerging cannabis industry and build lasting partnerships with other cannabis professionals.

If you are in the cannabis industry or are thinking of getting involved, ICBC Barcelona is one of the events not to be missed.

It will be held on 10 March 2022 at the Auditori de Cornellà.

In addition to the Barcelona conference, ICBC will meet in Berlin (18, 19, and 20 July) and Zurich (8 and 9 September).

__

(Photo by Dorian D1 via Unsplash)

DISCLAIMER: This article was written by a third-party contributor and does not reflect the opinion of Hemp.im, its management, staff, or its associates. Please review our disclaimer for more information.

This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.

First published in NewsWeed, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.

Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Hemp.im assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Hemp.im is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.